Veracyte (VCYT) Net Income towards Common Stockholders (2012 - 2026)
Veracyte's (VCYT) quarterly Net Income towards Common Stockholders came in at $25.5 million in Q2 2026, up 2701.02% year-over-year from $910025.5 in Q2 2025, and down 11.1% quarter-over-quarter from $28.7 million in Q1 2026.
Powered by 
Analysis
Veracyte (VCYT) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
Veracyte has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting $25.5 million for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 2701.02% year-over-year to $25.5 million; the TTM figure through Jun 2026 stood at $114.5 million (up 334.77% YoY), while the FY2025 annual figure was $66.4 million, up 174.89% from the prior year.
- Net Income towards Common Stockholders came in at $25.5 million for Q2 2026 at Veracyte, down from $28.7 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $41.2 million in Q4 2025 to a low of -$29.6 million in Q3 2023.
- Average Net Income towards Common Stockholders over 5 years is $1.9 million, with a median of -$1.4 million recorded in 2024.
- Year-over-year, Net Income towards Common Stockholders tumbled 630.33% in 2023 and soared 2701.02% in 2026.
- Over 5 years, Net Income towards Common Stockholders stood at -$3.9 million in 2022, then plunged by 630.33% to -$28.3 million in 2023, then surged by 118.16% to $5.1 million in 2024, then surged by 701.75% to $41.2 million in 2025, then tumbled by 38.11% to $25.5 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $25.5 million in Q2 2026, $28.7 million in Q1 2026, and $41.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -66.93 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 324.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 299.10 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -120.14 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 8.51 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -637,000.00 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 53.64 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 8.05 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -16.21 Mn |
| 10 | Veracyte | 3.20 Bn | 2.90 Bn | 108.55 Mn | 25.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.49 Mn |
| Mar 31, 2026 | 28.67 Mn |
| Dec 31, 2025 | 41.19 Mn |
| Sep 30, 2025 | 19.14 Mn |
| Jun 30, 2025 | -980,000.00 |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 15.15 Mn |
| Jun 30, 2024 | 5.73 Mn |
| Mar 31, 2024 | -1.86 Mn |
| Dec 31, 2023 | -28.29 Mn |
| Sep 30, 2023 | -29.57 Mn |
| Jun 30, 2023 | -8.40 Mn |
| Mar 31, 2023 | -8.09 Mn |
| Dec 31, 2022 | -3.87 Mn |
| Sep 30, 2022 | -8.68 Mn |
| Jun 30, 2022 | -9.53 Mn |
| Mar 31, 2022 | -14.46 Mn |
| Dec 31, 2021 | -10.52 Mn |
| Sep 30, 2021 | -14.08 Mn |
API Access
Veracyte Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VCYT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "VCYT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=VCYT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();